Тель-Авівте ең жақсы онкологияның онкологтар - ЖОҒ-53 дәрігерлер

Coping with gastrointestinal and lung cancer without chemotherapy. Specialists at the Tel Aviv Sourasky Clinic (Ichilov) use an ultra-modern innovative method to combat neuroendocrine tumors. It is based on radionuclide therapy with the radioisotope Lutetium 177 (Lutetium-177). This innovation is a real breakthrough in oncotherapy, because in recent decades the number of cases of this type of cancer has been rapidly growing.

This method is completely new in the world. Today it exists only in Israel, Germany and Sweden.

Its essence is in the use of a new radiopharmaceutical - Lutetium 177 PRRT. The drug is administered intravenously at intervals of 7-8 weeks. With the help of Lutetium, cancer cells are destroyed selectively, without affecting healthy tissues of the body. That is, this method of treatment can literally be called "local radiation therapy". In addition, the drug does not have a toxic effect on the bone marrow and kidneys, destroying the tumor from the inside.

In addition, the use of this method allows patients to avoid severe side effects of chemotherapy, such as vomiting, nausea, pain, alopecia, weakness. It is also important that the treatment is carried out by a special group of medical specialists. Among them: leading doctors, nurses and medical physicists!

All of them work under the supervision of Dr. Inna Ospovat, a leading specialist in the nuclear therapy department at the Ichilov Clinic.

Education

2000-1994 Faculty of Medicine in Vitebsk, Belarus.

Specialization

2003 - 2011 - specialization in oncology and radiation therapy at the Hadassah University Hospital in Jerusalem.

Recognized experience

Oncology and radiation therapy

Additional education

2015 - PMH University Hospital (Totonto) Childhood irradiation and head and neck tumors

Attending conferences

About 10 presentations at medical conferences

Trade union membership

• Israel Society of Clinical Oncology and Radiotherapy ISCORT
• American Association of Radiation Therapy ASTRO
• Israel Head and Neck Oncology Association
• Areas of special interest and activities
• Radiation therapy in children
• Radiobiological treatment PRBT
• Radiation therapy for gastrointestinal tumors
• Treatment of head and neck tumors and skin tumors

Education

Faculty of Medicine: Sackler Faculty of Medicine, Tel Aviv University

Specialization

Institute of Oncology, Davydov Center, Beilinson Hospital

Recognized experience

Medical Oncology and Radiation Therapy

Additional education

Department of Radiation Therapy, Duke University Medical Center, USA

Clinical experience

• 2004-2005 - Internship at Beilinson Hospital.
• 2006-2012 - Internship in oncology, Institute of Oncology, Davydov Center, Beilinson Hospital.
• 2012-2017 - Senior Physician, Head of the Department of Radiosurgery and Radiation Therapy for Nerve Tumors, Institute of Oncology, Davydov Center, Beilinson Hospital.
• 2015-2016 - Advanced training in radiosurgery and radiation therapy of brain and cervical tumors, Department of Radiation Therapy, Duke University Medical Center, USA
• 2017 onwards - Director of the Radiation Service for Nervous System Tumors, Institute of Oncology, Tel Aviv Medical Center.

Attending conferences

About 15 professional publications

Trade union membership

• Israel Association of Oncology and Radiotherapy
• International Association of Neuro-Oncologists - SNO
• Israel Forum of Neuro-Oncology
• Israel Head and Neck Tumor Society

Areas of special interest and activities

Cerebral metastases and primary brain tumors, head and neck tumors, radiation therapy and radiosurgery

Education/Residency:

• Completed residency in general oncology and radiotherapy (radiation therapy) at Sheba Hospital, Tel Hashomer.
• During her work, she gained extensive experience in treating tumors of the female reproductive system and is currently a coordinator for the treatment of patients suffering from these diseases.
• Fellowship - Anderson Cancer Center, Houston, Texas - 2012-2014

Dr. Tatyana Rabin's research interests include:

Methods of destruction of malignant neoplasms by heating with the help of ultrasonic waves, research into the use of brachytherapy in the treatment of oncogynecological diseases,

study of the mechanisms of response at the molecular level of prostate tumor cells to radiotherapy;

clinical studies of oncomammology, oncopulmonology, ocular lymphoma.

Dr. Rabin is investigating the molecular mechanisms by which prostate cancer cells respond to radiation therapy. This research is being conducted in collaboration with the Weizmann Institute of Science.

In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Dr. Rabin is currently coordinating a new and unique study at Sheba Hospital that is investigating a method of treating cancerous tumors using MRI-guided ultrasound waves. This method involves raising the tumor's temperature to a certain level and then destroying it.

Awards:

Dr. Tatyana Rabin was recognized as the best hospital employee for 2007.

Experience and participation in scientific research:

• Scientific research in the field of gynecological oncology
• Scientific research in the field of lung tumors
• Application of brachytherapy in oncogynecology
• SBRT techniques in the treatment of tumors of the respiratory system
• Study of molecular mechanisms of prostate tumor cell response to radiation therapy. This study was organized in collaboration with the laboratory of the H. Weizmann Institute.
• In addition, Dr. Rabin has been involved in clinical research in the areas of breast cancer, lung cancer, and ocular lymphoma.

Membership in medical societies :

• Israel Society of Oncology and Clinical Radiotherapy (ISCORT) American Society of Radiology and Oncology (ASTRO)
• Israel Association of Palliative Medicine

Professor Dan Grisaro is a leading Israeli specialist in gynecological cancer diagnosis and treatment, specializing in ovarian cancer, uterine cancer, and cervical cancer. He has senior physician, head of department and lecturer experience at various medical centers and universities. He has held 39 presentations and is the author of 83 published scientific articles, and is a member of various professional societies.

Prof. Jack Baniel is a Professor of Urology and Chief of Urology section at Rabin Medical Center, Petach Tikva, Israel. He specializes in the reconstruction of the bladder, robotic prostatectomy, cancer surgeries with preservation of the nerve endings. He has published over 100 scientific articles and is actively involved in research in the field of uro-oncology. He is a graduate of Tel Aviv University and is a member of various professional organizations, including the Israeli Medical Association, the Israeli Association of Urology, the European Association of Urology, the European Organization for Research and Treatment of Cancer (EORTC), and the American Association of Urology.

Professor Shlomi Constantini is a highly-trained neurosurgeon in Israel with expertise in general and pediatric neurosurgery, microsurgical operations, reconstructive interventions, and brain and spine tumor treatments. He has received several awards and is a member of multiple professional organizations.

Professor, Oncologist

Radiotherapist

Dr. Avi Hefetz  is Head of the department of surgery and head and neck oncology at the medical center head and neck surgery at  Melanoma Unit department of the largest Israel hospital - Assuta. Leading specialist in the diagnosis and surgical treatment of tumors in the head and neck, as well as, where appropriate, non-surgical treatment of the disease.

Clinical practice of doctor Hefetz combined with teaching and research activities, he teaches at Tel Aviv University, is the author of over 70 scientific articles which are published in various professional journals, has spent more than 40 scientific presentations.


 

Chief Physician of the Oncology Center, Oncologist

Surgeon, Specialist in Laparoscopic and Colorectal Surgery

Urologist, Specialist in Oncourology

Prof. Moshe Inbar is an Israeli oncologist and the Head of Department of Oncology at Sourasky (Ichilov) Medical Center, specializing in breast cancer, cancer of the uterus and ovaries, urogenital cancer in female and male, and gastro-intestinal cancer. He is a Clinical Associate Professor in Tel Aviv University, holds numerous awards and is a member of various research organizations.

Oncosurgeon

Dr. Riad Hadad is a leading Israeli surgeon and oncologist. He specializes in surgical treatment of gastrointestinal and liver cancer.

Education and professional experience

• Faculty of Medicine, Technion Institute of Medicine in Haifa, Israel;
• Internship at Carmel Medical Center, Haifa, Israel;
• specialization in general surgery at Tel Aviv University, Israel;
• specialization in the field of oncology of the gastrointestinal tract and liver at the medical center of the University of Toronto, Canada;
• Today, Dr. Hadad heads the department for the treatment of the liver, pancreas, and gallbladder at Assuta Clinic.

Scientific activity

Dr. Riad Hadad is the author of 60 scientific publications and a speaker at international symposia and conferences.

Membership in international associations

• Israel Medical Association;
• Israel Surgical Society;
• Israeli Society of Surgical Oncology;
• Association of Surgical Oncologists;
• European Society of Surgical Oncology;
• European Hepato-Pancreato-Biliary Association.